Skip to main content
Main Menu
  • Capabilities
    Back
    Capabilities
    • Assembly
    • Catheter Design
    • High Purity Specialty Closures
      Back
      High Purity Specialty Closures
      • Closure Assemblies
      • Liners
    • COVID-19 Rapid Manufacturing Capabilities
    • Custom Compounding
    • Custom Filtration
    • Medical Extrusion
    • Medical Molding
    • Prototyping and Tooling
    • Product Co-Development
  • Materials
    Back
    Materials
    • Fluoropolymers
      Back
      Fluoropolymers
      • Basics 101: Fluoropolymers
    • Other Materials
    • Silicone
      Back
      Silicone
      • Basics of Silicone:101
    • Thermoplastics
      Back
      Thermoplastics
      • Basics 101: Thermoplastics
      • PEEK page
  • Markets
    Back
    Markets
    • Cardiology
    • Diabetic Care
    • Drug Delivery
    • Nephrology
    • Ophthalmology
    • Other Medical Markets
    • Surgery
  • Resources
    Back
    Resources
    • Schedule a Lunch and Learn
    • Technical Data and Literature
    • White Papers
      Back
      White Papers
      • Effect of Sterilization on the Mechanical Properties
      • Extruded Silicone Tubing with Optimized Precision for medical device manufacturers
      • Flow Rate Stability of Medical Peristaltic Pump Tubing Materials
      • Liquid Silicone Rubber Injection Molding
      • Low Coefficient of Friction Materials: Tygon® LCF Offers the Ideal Combination
      • The Impact of Gamma and Autoclave Sterilization on Silicone Tubing
      • Two-Shot Silicone-Thermoplastic Medical Molding
    • Quality and Regulatory
      Back
      Quality and Regulatory
      • ISO Certifications
      • Medical Product Disclaimer
    • FAQs
    • Videos
  • About Us
    Back
    About Us
    • Events
    • Blog
    • News
    • Case Study
  • Contact Us
world SAINT-GOBAIN
Logo Saint-Gobain Medical
  • Capabilities
    • Assembly
    • Catheter Design
    • High Purity Specialty Closures
      • Closure Assemblies
      • Liners
    • COVID-19 Rapid Manufacturing Capabilities
    • Custom Compounding
    • Custom Filtration
    • Medical Extrusion
    • Medical Molding
    • Prototyping and Tooling
    • Product Co-Development
  • Materials
    • Fluoropolymers
      • Basics 101: Fluoropolymers
    • Other Materials
    • Silicone
      • Basics of Silicone:101
    • Thermoplastics
      • Basics 101: Thermoplastics
      • PEEK page
  • Markets
    • Cardiology
    • Diabetic Care
    • Drug Delivery
    • Nephrology
    • Ophthalmology
    • Other Medical Markets
    • Surgery
  • Resources
    • Schedule a Lunch and Learn
    • Technical Data and Literature
    • White Papers
      • Extruded Silicone Tubing with Optimized Precision for medical device manufacturers
      • Two-Shot Silicone-Thermoplastic Medical Molding
      • The Impact of Gamma and Autoclave Sterilization on Silicone Tubing
      • Low Coefficient of Friction Materials: Tygon® LCF Offers the Ideal Combination
      • Liquid Silicone Rubber Injection Molding
      • Flow Rate Stability of Medical Peristaltic Pump Tubing Materials
      • Effect of Sterilization on the Mechanical Properties
    • Quality and Regulatory
      • Medical Product Disclaimer
      • ISO Certifications
    • FAQs
    • Videos
  • About Us
    • Events
    • Blog
    • News
    • Case Study
  • Contact Us
COVID-19 Rapid Manufacturing Capabilities – LEARN MORE

You are here

  1. Home
  2. About Us
  3. News
  4. Saint-Gobain Acquires MS Techniques and Transluminal

Saint-Gobain Acquires MS Techniques and Transluminal

September 14th, 2020

Saint-Gobain Life Sciences Acquires France-based MS Techniques and Transluminal, Expanding its Offerings in the Minimally Invasive market

September, 14 2020

Saint-Gobain Life Sciences is broadening its medical components capabilities with the acquisition of MS Techniques and Transluminal while also establishing a European Medical Center for Excellence. The 137-person company, located in Pompey near Nancy (France), brings to Saint-Gobain years of experience in high-precision thermoplastic extrusion and design expertise for minimally invasive catheter solutions with a strong focus into the cardiovascular market. The company’s design and manufacturing capabilities will be complemented by Saint-Gobain’s material expertise, financial strength, and global presence in the medical device market. MS techniques and Transluminal will be integrated within Saint-Gobain Life Sciences’ Medical Components business unit.

At their core, both companies are very similar, and have customized, co-development models, and similar corporate cultures. Saint-Gobain is building on these synergies to bring customers the very best of both companies.

"We are looking forward to welcoming MS Techniques and Transluminal to the Saint-Gobain Medical family. Aligning with our growth strategy, they strengthen our presence in Europe, broaden our precision extrusion capabilities and catheter design expertise, helping us further expand into the interventional and minimally invasive market." says John Schmitz, General Manager for Saint-Gobain’s Medical Components and Electronics

MS Techniques and Transluminal have a strong track record of developing new catheter solutions that fit the needs of their customers. Saint-Gobain will focus on preserving, supporting, and further investing in the company’s rich culture of innovation.

"We decided to join forces with Saint-Gobain because we felt we found a true partnership and shared the same vision: to become a world-class reference in the medical device industry for delivering minimally invasive innovation. Joining a global medical organization with the size and tremendous legacy of Saint-Gobain makes it possible to carry forward what we have worked so hard to build over the last 28 years. With more resources and the Saint-Gobain brand supporting our efforts, we pave the way for future innovation and the co-development of new medical solutions with our customers." Etienne Malher, President MS Techniques

ABOUT SAINT-GOBAIN LIFE SCIENCES

Dedicated to improving the quality of life, Saint-Gobain Life Sciences develops and manufactures high-performance components and integrated solutions that touch a broad range of patient care, from the development of new therapeutic cancer treatments to biopharmaceutical production, on through to intravenous therapies for drug delivery.

Along with material science expertise and collaborative design services, our focus on global quality and regulatory affairs allow us to be the trusted partner to organizations reaching every part of the globe. Combining our technical expertise, global manufacturing capabilities and research and development resources, Saint-Gobain Life Sciences is dedicated to meeting the evolving needs of bioprocess, medical and pharmaceutical customers around the world. Saint-Gobain Life Sciences is part of Compagnie de Saint-Gobain.

Compagnie de Saint-Gobain designs, manufactures and distributes materials and solutions which are key ingredients in the wellbeing of each of us and the future of all. They can be found everywhere in our living places and our daily life: in buildings, transportation, infrastructure and in many industrial applications. They provide comfort, performance and safety while addressing the challenges of sustainable construction, resource efficiency and climate change. Saint-Gobain operates in 70 countries with more than 180,000 employees worldwide. The Company had €42.6 billion in sales in 2019.

www.medical.saint-gobain.com

Media Contact:

Vanessa Gagnon:

440-485-1334

Vanessa.gagnon@saint-gobain.com

About Saint-Gobain

Saint-Gobain designs, manufactures and distributes materials and solutions which are key ingredients in the wellbeing of each of us and the future of all. They can be found everywhere in our living places and our daily life: in buildings, transportation, infrastructure and in so many industrial applications.

 

Saint-Gobain Performance Plastics' group of businesses gather solutions to save energy, provide protection, improve comfort and sustain the environment for a variety of markets.

MENU

Capabilities
Materials
Markets
Resources
FAQs
About Us
Contact Us
Schedule a Lunch and Learn
Legal
CATSCA

 

 

 

FOLLOW US

 

 CONTACT US

Saint-Gobain’s medical products are distributed exclusively to medical device manufacturers for use in the manufacture, assembly or distribution of their medical devices. Saint-Gobain cannot authorize the sale of its medical products directly to device user facilities (e.g. hospitals, surgery centers, nursing home, clinics, etc.), nor directly to end users (e.g. patients, patients’ caregiver, prescribing physician, nurse, pharmacist, etc.), including distributors serving device user facilities and end users directly. In accordance with every jurisdiction globally, Saint-Gobain’s customers are responsible for determining that any medical device they manufacture and market that incorporates a Saint-Gobain’s medical product, is compliant with each country-specific medical device regulations and has received proper country-specific clearance, certification or registration authorizing the sale of this medical device.


Saint-Gobain’s medical products offer covers:
- Medical Components [21 CFR 820.3(c)], intended for processing or use in the manufacture or assembly of medical devices before the finished medical device is packaged/labeled; Medical Components are intended to be included as part of the finished, packaged, and labeled device [21CFR820.3(c)].
- Finished Devices [21CFR820.3(l)] made on behalf of medical device manufacturers [21 CFR 807.20(a)(2)] under contract-manufacturing agreement. In accordance with the United States’ jurisdiction, Saint-Gobain complies with the FDA’s requirements for contract manufacturers of finished devices.

© Copyright Saint-Gobain 2019. All rights reserved.